Stocktoria
Profound Medical Corp. PROF
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2014-09-24
Profound Medical Corp. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Gross margin | 70.8% | 65.9% | 59.9% |
| Operating margin | -256.3% | -309.6% | -398.0% |
| Net margin | -264.4% | -260.4% | -393.4% |
| FCF margin | -238.4% | — | — |
| Return on assets | -54.9% | -39.6% | -64.4% |
| Return on equity | -64.1% | -46.0% | -90.7% |
| Debt / equity | 0.07× | 0.08× | 0.23× |
| Current ratio | 12.52 | 10.52 | 6.58 |
| Revenue growth | 50.7% | 48.4% | — |
Source: SEC EDGAR filings · CIK 0001628808 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.